Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Sitravatinib
Nivolumab
+2 more
Locations
36
United States
The University of Arizona Cancer Center
Tucson, Arizona, United States
University of California Irvine
Irvine, California, United States
Rocky Mountain Cancer Centers
Aurora, Colorado, United States
Yale School of Medicine
New Haven, Connecticut, United States
SCRI - Florida Cancer Specialists- North Region
St. Petersburg, Florida, United States
Moffitt Cancer Center
Tampa, Florida, United States
Start Date
September 11, 2018
Primary Completion Date
August 3, 2022
Completion Date
August 22, 2022
Last Updated
August 24, 2023
NCT06857175
NCT04693377
NCT04895709
NCT06948552
NCT05987241
NCT07061964
Lead Sponsor
Mirati Therapeutics Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions